Lausanne-based startup Testmate Health has raised USD 6 million of funding to boost the development and commercialization of their at-home rapid test for sexually transmitted infections STI. The investment round was led by RH Capital with participation from notable co-investors including the Zürcher Kantonalbank and New York City-based venture firm The Helm.
![USD 6 million to fight a silent epidemic](https://republic-of-innovation.ch/wordpress/wp-content/uploads/2024/05/TestmateHealthKit-630x317.jpg)